Trials / Completed
CompletedNCT02287961
Human Papillomavirus Infection and Related Anal Lesions in HIV-positive Men Who Have Sex With Men
Natural History of Anal Human Papillomavirus Infection and Associated Disease in HIV-infected Men Who Have Sex With Men: Towards an Evidence Base for the Prevention of Anal Cancer.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 516 (actual)
- Sponsor
- ANRS, Emerging Infectious Diseases · Other Government
- Sex
- Male
- Age
- 35 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Multicentric epidemiological non-comparative study in France characterising evolution of anal Human papillomavirus (HPV) infection and related lesions and evaluating markers associated with the observed evolution. Estimated enrolment: 500 Principal Outcomes * Detection of high-grade cytological and histological anal lesions by high resolution anoscopy * Spontaneous regression of high-grade anal lesions * Detection of anal HPV infection Intervention (procedure): * Patient medical interview (initial inclusion visit, Month 12 and Month 24 follow-up visits and if applicable Month 6 and Month 18 control visits) * Standard proctologic examination with digital rectal examination and 2 anal swabs (initial inclusion visit, Month 12 and Month 24 follow-up visits and if applicable Month 6 and Month 18 control visits) * High resolution anoscopy (initial inclusion visit, Month 12 and Month 24 follow-up visits and if applicable Month 6 and Month 18 control visits) Only if lesion suggestive of Anal Intraepithelial Neoplasia (AIN) detected during High Resolution Anoscopy (HRA): \- anal biopsy(ies) during HRA Only if high-grade lesion: \- HRA biannually
Detailed description
Intervention (procedure): * Patient medical interview (initial inclusion visit, Month 12 and Month 24 follow-up visits and if applicable Month 6 and Month 18 control visits) * Standard proctologic examination with digital rectal examination and 2 anal swabs (initial inclusion visit, Month 12 and Month 24 follow-up visits and if applicable Month 6 and Month 18 control visits) * High resolution anoscopy (initial inclusion visit, Month 12 and Month 24 follow-up visits and if applicable Month 6 and Month 18 control visits) Only if lesion suggestive of Anal Intraepithelial Neoplasia (AIN) detected during High Resolution Anoscopy (HRA): \- anal biopsy(ies) during HRA Only if high-grade lesion (Atypical squamous cells-cannot exclude high-grade squamous intraepithelial lesion (ASC-H), High grade Superficial Intra-epithelial Lesion (HSIL) or AIN2/3): \- HRA biannually
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Standard proctologic examination | (with digital rectal examination and 2 anal swabs) at initial inclusion visit, M12 and M24 follow-up visits and if applicable M6 and M18 control visits |
| PROCEDURE | High resolution anoscopy | at initial inclusion visit, Month 12 and Month 24 follow-up visits and if applicable Month 6 and Month 18 control visits |
| PROCEDURE | Biopsy(ies) during High Resolution Anoscopy | only if lesion suggestive of AIN detected during High Resolution Anoscopy |
| PROCEDURE | High Resolution Anoscopy biannually | Only if high-grade lesion (ASC-H, HSIL ou AIN2/3) |
Timeline
- Start date
- 2014-12-02
- Primary completion
- 2022-06-30
- Completion
- 2022-06-30
- First posted
- 2014-11-11
- Last updated
- 2024-08-20
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02287961. Inclusion in this directory is not an endorsement.